Translocation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Lorlatinib Combinations in Lung Cancer
Conditions:   Lung Cancer;   Anaplastic Lymphoma Kinase Gene Translocation;   ROS1 Rearrangement;   Relapsed Cancer;   MET Amplification;   Resistant Cancer Interventions:   Drug: Lorlatinib;   Drug: Crizotinib;   Drug: Binimetinib Sponsors:   Massachusetts General Hospital;   Array BioPharma;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials